Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 11 April

Sophia Mavridis
April 11, 2022

Weekly Wrap 8 April

Sophia Mavridis
April 8, 2022

Morning Bell 7 April

Paulina Peters
April 7, 2022

Morning Bell 6 April

Paulina Peters
April 6, 2022

Morning Bell 5 April

Sophia Mavridis
April 5, 2022

Morning Bell 4 April

Sophia Mavridis
April 4, 2022

Weekly Wrap 1 April

Sophia Mavridis
April 1, 2022

Morning Bell 31 March

Paulina Peters
March 31, 2022

Morning Bell 30 March

Sophia Mavridis
March 30, 2022

Morning Bell 29 March

Paulina Peters
March 29, 2022